New
Products
We
are continually looking for quality new products for our customers.
Details of the latest additions to our catalogue can be seen below: |
|
| New
products from Hyphen |
|
|
| |
Hyphen
Hemoclot Thrombin Inhibitors and Biophen DTI
are highly sensitive clotting and chromogenic assays (respectively)
for the quantitative measurement of hirudin and other direct thrombin
inhibitors in human plasma.
• Use of highly purified human thrombin (alpha form)
• Linear dose response curve (even at concentrations >0.1ug/ml)
• No interference from prothrombin or fibrinogen
• Evaluation of the ‘true’ direct anti-thrombin
activity of the DTI
• Reproducable and consistent from run to run and lot to lot
• Cost effective |
|
| |
Hyphen
Zymutest HIA ELISA Assays
• Uniquely presented biologically available bound unfractionated
heparin improves sensitivity and specificity
• Range of kits to screen and if desired, isotype
• Easy to use familiar ELISA format
• Can be automated
• Split into strips for greater convenience, ideal for low test
numbers
• Very competitively priced |
|
| |
Hyphen
Hemoclot Quanti V-L
• Next generation assay
• Identifies all FV mutations that lead to APC Resistance
• 100% agreement with PCR
• Quantitative:
- Only one assay per sample, saves time and money
- No disruption of results by batch to batch variation
- No need to establish a cut-off
- No need for normalisation
- No overlap of normals, heterozygotes or homozygotes
• Therefore much easier to use with higher confidence in results
|
|
| |
Hyphen
Biophen FVIII:C
• Chromogenic Assay
• Utilises the outstanding technical performance of the Hyphen
purified human proteins
• Designed with highly characterised, therefore reliable reproducible,
synthetic phospholipids
• Complies with European Pharmacopea recommendations
• Avoids any factor reagent depletion during assays by using
a large excess if Factor X
• Can be used for high and low working ranges
• All of the above make it a highly suitable kit for measuring
concentrates, high levels of FVIII in plasma, diagnosis of von Willebrand
disease and for Haemophilia A. |
|
| |
Hyphen
Zymuphen MP-Activity
Building on unique research Hyphen have developed an easy to use
ELISA based assay for the measurement of Procoagulant Microparticle
activity.
• Highly sensitive assay, even suitable for MP as small as
0.1m
• The kit can be used for many clinical applications i.e.
diagnosis, prognosis and therapy monitoring
• download
pdf |
|
| Cusabio
Biotech Co Ltd Research ELISA kits |
|
|
| |
CUSABIO
BIOTECH Co Ltd is a biotech company that manufactures high
quality reagents for use in the field of research. The main product
range primarily consists of ELISA kits and some recombinant proteins.
They have over 4000 ELISA kits for different species and expression
systems for hundreds of recombinant proteins.
Product list for download
If you are interested in any of the Cusabio range please do not
hesitate to contact us for further information and pricing.
|
|
| Biosynex
Immunoquick EBV Assays |
|
|
| |
Early
detection of Epstein Barr virus (EBV) with a rapid two minute test
IMMUNOQUICK®
filtration EBV IgM from BIOSYNEX gives early detection of primary
infection utilising a mixture of ZEBRA & VCA p18 antigens. Combined
with IMMUNOQUICK® filtration EBV IgG, the stage of infection
can be interpreted.
0515-K25 IMMUNOQUICK® filtration EBV M
0516-K25 IMMUNOQUICK® filtration EBV G
Immunoquick®
EBV presentation download |
|
| Quadratech
CHECK4®FLU A/B |
|
|
| |
A
New rapid test from Quadratech for Influenza A and Influenza B viruses
CHECK4®FLU A/B is a rapid immunochromatographic test utilising
a dual cassette to test each virus separately from a single specimen
preparation.
Running the two tests individually avoids a high antigen load of one
virus causing antigen excess and false positive results for the second
virus.
Product code: QBX020FLUAB 20 tests |
|
| Easy
Reader |
|
|
|
|
The
EASY READER is an innovative meter for quantitative measurement of immunochromatographic rapid tests
results. The meter utilises a high resolution closed circuit digital
camera and integrated software to generate results. The Easy Reader
removes any operator subjectivity and ensures the cassettes are
read at the correct time interval.
Available
Tests:
• Quantitative hCG (serum / urine)
Under Evaluation:
• Quantitative D-Dimer (serum / plasma / whole blood)
Coming soon:
• Quantitative Microalbumin (urine)
• Quantitative Faecal Occult Blood (faeces) |
|
| Affinity
Visulize FIX Antigen Assay |
|
|
| |
•
Rapid ELISA to measure FIX antigen (FIX:Ag)
• 70 minutes total incubation time
• FIX:Ag reported as International Units/mL traceable to WHO
standard for FIX activity
• Detection limit to 0.005 IU/mL FIX:Ag (0.5%)
• Includes normal and low controls
• Up to 4 assay events per kit |
|
| Bordier
Microsporidia IFA monoclonal antibodies |
|
|
| |
Microsporidia
Bordier now produce IFA monoclonal antibodies for
Microsporidia. Product code 8100:
2 x 0.5 ml anti-Enterocytozoon bieneusi monoclonal antibody,
ready to use
2 x 0.5 ml anti-Encephalitozoon intestinalis monoclonal
antibody, ready to use
1 x 2.0 ml anti-mouse IgG Alexafluor 488 conjugate, ready to use
Instructions for the staining procedure.
Enterocytozoon
bieneusi and Encephalitozoon intestinalis are important
opportunistic pathogens. These intracellular protists predominantly
infect the epithelium of the small intestine causing chronic diarrhoea
and malabsorption in acquired immunodeficiency syndrome or after
organ transplantation in recipients treated with powerful immunosuppressors.
The most common microsporidial infection in humans is caused by
E. bieneusi. There is a high prevalence of enteric carriage
of E. bieneusi amongst immunocompetent persons in tropical
countries where this parasite naturally persists in the human population.
Double infections with the two parasites might also occur.
In recent years, clinical cases caused by microsporidia decreased
due to the administration of highly antiretroviral therapy restoring
immunity. However, microsporidian parasites are not eliminated in
all patients and relapses can be observed. Healthy persons, especially
travellers returning from tropical areas and immunosuppressed patients
undergoing organ transplantation are still at risk from such opportunistic
infections. |
|
